Biochemical verification of tobacco use and cessation

Nicotine and Tobacco Research

Volumn 4, Issue 2, 2002, Pages 149-159

  Benowitz, Neal L ^a   Jacob, Peyton ^a   Ahijevych, Karen ^b   Jarvis, Martin J ^c   Hall, Sharon ^a   LeHouezec, Jacques ^d   Hansson, Anna ^d   Lichtenstein, Ed ^e   Henningfield, Jack ^f   Tsoh, Janice ^a   Hurt, Richard D ^g   Velicer, Wayne ^h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d Pharmacia Consumer Health Care ^*

^e OREGON RESEARCH INSTITUTE   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID DERIVATIVE; ANABASINE; ANATABINE; BIOLOGICAL MARKER; CARBON MONOXIDE; COTININE; NICOTINE; THIOCYANATE; UNCLASSIFIED DRUG;

BEHAVIOR; BIOCHEMISTRY; CIGARETTE SMOKING; DISEASE SEVERITY; HUMAN; MEDICAL DECISION MAKING; NICOTINE REPLACEMENT THERAPY; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; REVIEW; SELF REPORT; SENSITIVITY AND SPECIFICITY; SMOKING CESSATION; TIME; TOBACCO DEPENDENCE; VALIDATION PROCESS;

BIOLOGICAL MARKERS; HUMANS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SMOKING; SMOKING CESSATION; TIME FACTORS; TOBACCO USE DISORDER;

EID: 18444361814     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/14622200210123581     Document Type: Review

References (65)

1. Saliva cotinine as a measure of smoking status in field settings
2. Menthol, ethnicity, and cotinine in women cigarette smokers
3. Comparison of the measurement of serum cotinine levels by gas chromatography and radioimmunoassay
4. The direct barbituric acid assay for nicotine metabolites in urine. A simple colorimetric test for the routine assessment of smoking status and cigarette smoke intake
5. Toxicity of nicotine: Implications with regard to nicotine replacement therapy
6. Daily intake of nicotine during cigarette smoking
7. Metabolism of nicotine to cotinine studied by a dual stable isotope method
8. Cotinine disposition and effects
9. Stable isotope studies of nicotine kinetics and bioavailability
10. Ethnic differences in N-glucauronidation of nicotine and cotinine
11. Properties of saliva cotinine in young adult light smokers
12. Considerations of the physiological variables that determine the blood carboxyhemoglobin concentration in man
13. Community Intervention Trial for Smoking Cessation (COMMIT): Cohort results from a four-year community intervention
14. Criteria for the diagnosis of alcoholism
15. Use of high performance liquid chromatographic mass spectrometric (LC-MS) techniques for the determination of nicotine and its metabolites
16. Optimum cutoff points for biochemical validation of smoking status
17. High-dose nicotine patch therapy: Percentage of replacement and smoking cessation
18. Determination of nicotine and its metabolites in biological fluids in vivo studies
19. Dietary nicotine: A source of urinary cotinine
20. Determination of thiocyanate in plasma and saliva without deproteinisation and its validation as a smoking parameter
21. Accelerated metabolism of nicotine and cotinine in pregnant smokers
22. Measurement of thiocyanate in serum or urine yields different information
23. Measuring degree of physical dependence to tobacco smoke with reference to individualization of treatment
24. Measuring nicotine dependence: A review of the Fagerström Tolerance Questionnaire
25. Serum thiocyanate and smoking, interpretation of thiocyanate levels in a large study
26. Specificity of salivary thiocyanate as marker of cigarette smoking is not affected by alimentary sources
27. Direct spectophotometric determination of thiocyanate in plasma and urine with FIA
28. Biochemical validation of smoking status in public health settings: Pros, cons, and data from four low intensity intervention trials
29. Blood cotinine levels as indicators of smoking treatment outcome
30. Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers
31. Mood management and nicotine gum in smoking treatment: A therapeutic contact and placebo-controlled study
32. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking
33. A high-performance liquid-chromatographic method for routine simultaneous determination of nicotine and cotinine in plasma
34. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation
35. Use of gas chromatographic and mass spectrometric techniques for the determination of nicotine and its metabolites
36. Minor tobacco alkaloids as biomarkers for tobacco use: Comparison of cigarette, smokeless tobacco, cigar and pipe users
37. Carbon monoxide and thiocyanate levels in low tar/nicotine smokers
38. Comparison of tests used to distinguish smokers from nonsmokers
39. Elimination of cotinine from body fluids: Implications for non-invasive measurement of tobacco smoke exposure
40. Serum cotinine concentration and self-reported smoking during pregnancy
41. Use of immunoassay techniques for the determination of nicotine and its metabolites
42. Application of serum nicotine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy
43. Application of urine cotinine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy
44. Saliva cotinine as an indicator of cigarette smoking in adolescents
45. The validity of self-reported smoking: A review and meta-analysis
46. A simple, inexpensive urine test of smoking
47. Relationship between nicotine tolerance questionnaire scores and plasma cotinine
48. An automated colorimetric assay for urine metabolites: A suitable alternative to cotinine assays for the assessment of smoking status
49. Estimating the hazards of less hazardous cigarettes. II. Study of cigarette yields of nicotine, carbon monoxide and hydrogen cyanide in relation to levels of cotinine, carboxyhemoglobin, and thiocyanate in smokers
50. Evaluation of two biological markers of tobacco exposure
51. Effectiveness of the 4 mg dose of nicotine polacrilex for the initial treatment of high-dependent smokers
52. Carboxyhaemoglobin and plasma thiocyanate: Complementary indicators of smoking behavior?
53. Cotinine determination by immunoassays may be influenced by other nicotine metabolites
54. Saliva cotinine levels as a function of collection method
55. Kinetics of elimination of thiocyanate in 7 healthy subjects and in 8 subjects with renal failure
56. Reducing the confounding effect of environment and diet on saliva thiocyanate values in ex-smokers
57. Impact of smoking cessation on salivary function in healthy volunteers
58. Simple high-performance liquid chromatographic method to verify the direct barbituric acid assay for urinary cotinine
59. Assessing outcome in smoking cessation studies
60. Comparison of biochemical and questionnaire estimates of tobacco exposure
61. Cotinine levels in Southeast Asian smokers
62. Interference of nicotine metabolites in cotinine determination by RIA